Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

TIDES Asia: Oligonucleotide & Peptide Therapeutics
24-26 Feb, 2027
Grand Nikko Tokyo DaibaTokyo
Menu

Dr. Xin Zhang, PhD
Principal Scientist at Denali Therapeutics
Speaker

Profile

Dr. Xin Zhang is a Principal Scientist and analytical team leader at Denali Therapeutics with more than 15 years of experience in the pharmaceutical and biopharma industry. She specializes in the characterization of antisense oligonucleotides (ASOs), antibody–oligonucleotide conjugates (AOCs), and biologics, with expertise spanning metabolism, stability, and pharmacokinetics. Dr. Zhang earned her Ph.D. in Analytical Chemistry from the University at Buffalo, SUNY, and is a co-inventor on several U.S. patents.

Agenda Sessions

  • LC-HRMS Bioanalytical Strategies for Characterizing and Quantifying Antibody–Oligonucleotide Conjugate (AOC) Therapeutics

    , 2:45pm
    View Session

At this event

Prev
Next
Hiroshi Abe, PhD
Professor, Department of Chemistry, Graduate School
Nagoya University

See Xin at TIDES Asia: Oligonucleotide & Peptide Therapeutics